Results of myocardial revascularization in atrial fibrillation in combination with acute coronary syndrome in real clinical practice according to the total register of acute coronary syndrome in the Krasnodar Territory

• Kosmacheva E.D.
• Tatarintseva Z.G.
• Porkhanov V.A.

Abstract

The aim of the study was to evaluate the frequency and type of myocardial revascularization in the acute period of acute coronary syndrome (ACS) (percutaneous coronary angioplasty of the coronary artery) and/or in patients with in combination with ACS atrial fibrillation (AF) of the coronary substrate according to coronary angiography or thrombolytic therapy and in the delayed period 2-4 months after the ACS episode (aorto-coronary shunting), an assessment of the incidence of thromboembolic and hemorrhagic complications, hospital summer mortality and mortality 6-24 months after hospital discharge, as well as an assessment of the prognostic significance of the CHA2DS2VASc and HAS-BLED scales in real clinical practice. The study found that AF is associated with greater mortality both at the hospital stage of treatment, and after 6-24 months after discharge from hospital, and also involves a multiple increase in the risk of complications such as ischemic stroke and bleeding. The presence of hemorrhagic complications in the ACS + AF group is not related to the volume of antithrombotic therapy.

Keywords: acute coronary syndrome, atrial fibrillation, coronaroangiography, myocardial revascularization, lethality, register

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)